Bless Study (BLeeding Events and Maintenance DoSe of PraSugrel)

Trial Profile

Bless Study (BLeeding Events and Maintenance DoSe of PraSugrel)

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 03 Aug 2016

At a glance

  • Drugs Prasugrel (Primary) ; Aspirin
  • Indications Acute coronary syndromes; Embolism and thrombosis
  • Focus Adverse reactions
  • Acronyms BLESS
  • Most Recent Events

    • 28 Jul 2016 Status changed from recruiting to discontinued.
    • 20 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top